SCHEMBL7666349

SCHEMBL7666349

COc1ccc(NC(=O)Nc2ccnc3cc(Cl)ccc23)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 8/20 0.62
GRIK1 P39086 1/20 0.62
KDR P35968 9/20 0.61
GSK3A P49840 1/20 0.59
GSK3B P49841 1/20 0.59
MAPT P10636 3/20 0.57
KMT2A Q03164 3/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
MEN1 O00255 2/20 0.57
POLB P06746 2/20 0.57
NPC1 O15118 1/20 0.57
TP53 P04637 1/20 0.57
TSHR P16473 1/20 0.57
RAB9A P51151 1/20 0.57
HTR2C P28335 1/20 0.57
HTR2B P41595 1/20 0.57
CLK2 P49760 2/20 0.55
HIPK4 Q8NE63 2/20 0.55
SRPK1 Q96SB4 2/20 0.55
CLK4 Q9HAZ1 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656126 0.89 MAPT (0.63) PDGFRAGRIK1KDRGSK3AGSK3B
SCHEMBL1147612 0.85 NR4A2 (0.57) PDGFRA
SCHEMBL7663190 0.84 GAK (0.71) PDGFRAKDRGSK3AGSK3BKMT2A
SCHEMBL7370903 0.83 HTR2C (0.70) PDGFRAKDRGSK3AGSK3BMAPT
SCHEMBL21121632 0.83 MAPT (0.69) PDGFRAKDRMAPTKMT2APOLB
Hydrochloric Acid SCHEMBL7658423 0.81 HTR2C (0.67) PDGFRAKDRGSK3AGSK3BMAPT
SCHEMBL27953778 0.77 CYP1A2 (0.59) GSK3AGSK3BMAPTKMT2ASMN1; SMN2
SCHEMBL7492018 0.77 KDR (0.87) PDGFRAKDR
SCHEMBL31067639 0.77 PDGFRA (1.00) PDGFRAKDR
SCHEMBL3962093 0.77 GRIK1 (1.00) GRIK1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410529-B1 DIETETICS; NON-INSULIN DEPENDENT DIABETES; SLEEP DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2002-06-25 US claimed
US-6410529-B1 DIETETICS; NON-INSULIN DEPENDENT DIABETES; SLEEP DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2002-06-25 US disclosed